Cart
sales@molnova.com
Perivine
CAS No. 2673-40-7
Perivine( —— )
Catalog No. M18335 CAS No. 2673-40-7
Perivine may resolve the instability of the retinoblastoma-associated proteins (RbAp48) complex and thus be used in Alzheimer's disease therapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 104 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePerivine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPerivine may resolve the instability of the retinoblastoma-associated proteins (RbAp48) complex and thus be used in Alzheimer's disease therapy.
-
DescriptionPerivine may resolve the instability of the retinoblastoma-associated proteins (RbAp48) complex and thus be used in Alzheimer's disease therapy. Perivine, vobasine, coronaridine and dichomine show hypotensive and muscle relaxant activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2673-40-7
-
Formula Weight338.4
-
Molecular FormulaC20H22N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OC)C4[C@@H]3Cc1c(nc2ccccc12)C(=O)C[C@@H]4C(CN3)=[C@H]C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huang H J, et al. Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine.[J]. Biomed Research International, 2014, 2014(11):764946.
molnova catalog
related products
-
Atractylenolide III
Atractylenolide III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury.
-
Senkyunolide N
Senkyunolide N exhibits prostaglandin H endoperoxide synthase-I (COX-I) and endoperoxide synthase-II (COX-II)) Inhibitory activity at pH 7 and at a concentration of 250 pg ml(-1) .
-
Cbl-b-IN-5
Cbl-b-IN-5 is a potent CPL-B inhibitor with IC50 values between 3 and 10 μM. Cbl-b-IN-5 has been used to study cancer and diseases related to the immune system.
